Cargando…
Overview of nutritional approach in hematopoietic stem cell transplantation: COVID-19 update
The coronavirus disease 2019 (COVID-19) is caused by the newly discovered SARS-CoV-2. Hematopoietic stem cell transplantation (HSCT) is a high-risk procedure. The novelty of COVID-19 has created more uncertainty during all phases of HSCT. It is thought that HSCT patients taking immunosuppressive age...
Autores principales: | Akbulut, Gamze, Yesildemir, Ozge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567455/ https://www.ncbi.nlm.nih.gov/pubmed/34786156 http://dx.doi.org/10.4252/wjsc.v13.i10.1530 |
Ejemplares similares
-
Medical nutritional therapy for renal transplantation in the COVID-19 pandemic
por: Akbulut, Gamze, et al.
Publicado: (2021) -
Overview of the progress on haploidentical hematopoietic transplantation
por: Farhadfar, Nosha, et al.
Publicado: (2016) -
Psychosocial aspects of hematopoietic stem cell transplantation
por: Janicsák, Henrietta, et al.
Publicado: (2021) -
Considerations for hematopoietic stem cell transplantation in primary immunodeficiency disorders
por: Gavrilova, Tatyana
Publicado: (2019) -
COVID-19 pandemic: Its impact on liver disease and liver transplantation
por: Sahin, Tevfik Tolga, et al.
Publicado: (2020)